Sirio Pharma Co Ltd. Stock Analysis 300791.SZ

Sirio Pharma Co. Ltd. engages in the manufacturing dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,776 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm is committed to providing full chain solutions including basic research and product development, manufacturing, packaging, logistics and marketing support for customers in the global nutrition and health food industry. The firm's business scope covers functional food, special dietary food and health food. The firm primarily conducts its businesses in the domestic and overseas markets.